The Multiple Myeloma Program at Dana-Farber/Brigham and Women's Cancer Center focuses exclusively on developing better therapies for multiple myeloma and providing leading-edge treatments to our patients.
The Multiple Myeloma Program brings together a team of scientists and physicians dedicated to advancing the fundamental understanding and treatment of multiple myeloma.
As a patient here, you will receive a personalized treatment plan offering the latest therapies, including combination chemotherapy, novel biologically-based therapies, CAR T-cell therapy, and radiation therapy. Right now you have cancer. But what your cancer doesn't know is, you have us.
Our specialists have extensive